272
Views
21
CrossRef citations to date
0
Altmetric
Special Report

Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis

, &
Pages 719-729 | Published online: 10 Jan 2014

References

  • Sinha MK, Garg RK, Anuradha HK, Agarwal A, Parihar A, Mandhani PA. Paradoxical vision loss associated with optochiasmatic tuberculoma in tuberculous meningitis: a report of 8 patients. J. Infect.60, 458–466 (2010).
  • Sinha MK, Garg RK, Anuradha HK et al. Vision impairment in tuberculous meningitis: predictors and prognosis. J. Neurol. Sci.290, 27–32 (2010).
  • Anupriya A, Sunithi M, Maya T et al. Tuberculous optochiasmatic arachnoiditis. Neurol. India58, 732–735 (2010).
  • Gourie-Devi M. Optochiasmatic arachnoiditis and neurotuberculosis: prognostic indicators and therapeutic strategies. Neurol. India58, 714–715 (2010).
  • Balado M, Satanowsky P. Tratamiento quirúrgico de la atrofia de la papila. Arch. Argent. Neurol.4, 71–75 (1929).
  • Yuhl ET, Rand CW. Tuberculous optochiasmatic arachnoiditis. Report of a case. J. Neurosurg.8, 441–443 (1951).
  • De Lavergne V, Pierquin, Helluy, Martin JY. Complication of meningeal tuberculosis, optochiasmatic arachnoiditis; arrest of its development by cortisone used early. Rev. Med. Nancy79, 134–140 (1954).
  • Rougier J, Lapras C, Fischer G, Hullo A. Two new cases of optochiasmatic arachnoiditis in the infant and child. Bull. Soe. Ophtalmol. Fr.80, 179–183 (1980).
  • Scott RM, Sonntag VK, Wilcox LM, Adelman LS, Rockel TH. Visual loss from optochiasmatic arachnoiditis after tuberculous meningitis. Case report. J. Neurosurg.46, 524–526 (1977).
  • Iba-Zizen MT, Cabanis EA, Tamraz JC, Braun M, Lopez A, Godde-Jolly D. Magnetic resonance imaging of the opto-chiasmatic region. Report on 276 cases. Acta. Radiol. Suppl.369, 318–319 (1986).
  • Aylward EH, Karagiozis H, Pearlson G, Folstein MF. Suprasellar cistern measures as a reflection of dementia in Alzheimer’s disease but not Huntington’s disease. J. Psychiatr. Res.25, 31–47 (1991).
  • Garg RK. Tuberculous meningitis. Acta. Neurol. Scand.122, 75–90 (2010).
  • Subramanian PC. Bacteria and bacterial diseases. In: Walsh and Hoyt’s Clinical Neuro-ophthalmology. Volume 3 (6th Edition). Miller NR, Fletcher W (Eds). Lippincott Williams and Wilkins, Baltimore, MD, USA, 2647–2774 (2005).
  • Teoh R, Poon W, Humphries MJ, O’Mahony G. Suprasellar tuberculoma developing during treatment of tuberculous meningitis requiring urgent surgical decompression. J. Neurol.235, 321–322 (1988).
  • Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin. Infect. Dis.19, 1092–1099 (1994).
  • Nicolls DJ, King M, Holland D, Bala J, del Rio C. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect. Dis.5, 795–801 (2005).
  • Marais S, Scholtz P, Pepper DJ, Meintjes G, Wilkinson RJ, Candy S. Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome. Int. J. Tuberc. Lung Dis.14, 188–196 (2010).
  • Ray JC, Flynn JL, Kirschner DE. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol.182, 3706–3717 (2009).
  • Paige C, Bishai WR. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe’s point of view. Cell. Microbiol.12, 301–309 (2010).
  • Green JA, Thi Hong Chau T, Farrar JJ, Friedland JS, Thwaites GE. CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology76, 577–579 (2011).
  • Tsai MH, Huang YC, Lin TY. Development of tuberculoma during therapy presenting as hemianopsia. Pediatr. Neurol.31, 360–363 (2004).
  • Akhaddar A, El Hassani MY, Chakir N, Jiddane M. Optochiasmatic tuberculoma: complication of tuberculous meningitis: report of a case and review of the literature. J. Neuroradiol.28, 137–142 (2001).
  • Sharma K, Pradhan S, Varma A, Rathi B. Irreversible blindness due to multiple tuberculomas in the suprasellar cistern. J. Neuro-Ophthalmol.23, 211–212 (2003).
  • Beneggi A, Adamoli P, Bernardini E et al. Tuberculous meningitis: a case with severe ocular complications. Pediatr. Med. Chir.17, 465–469 (1995).
  • Dautremer J, Pacanowski J, Girard PM, Lalande V, Sivignon F, Meynard JL. A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis. AIDS21, 381–382 (2007).
  • Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J. Neurol. Sci.303, 22–30 (2011).
  • Bernaerts A, Vanhoenacker FM, Parizel PM et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur. Radiol.13, 1876–1890 (2003).
  • Clavier E, Thiebot J, Freger P, Mihout B, Bernet J, Benozio M. Optochiasmatic tuberculoma and MRI: 2 cases. J. Radiol.69, 333–337 (1988).
  • Aversa do Souto A, Fonseca AL, Gadelha M, Donangelo I, Chimelli L, Domingues FS. Optic pathways tuberculoma mimicking glioma: case report. Surg. Neurol.60, 349–353 (2003).
  • Marcus AO, Demakas JJ, Ross HA, Duick DS, Crowell RM. Optochiasmatic arachnoiditis with treatment by surgical lysis of adhesions, corticosteroids, and cyclophosphamide: report of a case. Neurosurgery19, 101–103 (1986).
  • Navarro IM, Peralta VH, Leon JA, Varela EA, Cabrera JM. Tuberculous optochiasmatic arachnoiditis. Neurosurgery9, 654–660 (1981).
  • Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med.351, 1741–1751 (2004).
  • Green JA, Elkington PT, Pennington CJ et al.Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-κB- and activator protein-1-dependent monocyte networks. J. Immunol.184, 6492–6503 (2010).
  • Green JA, Tran CT, Farrar JJ et al. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS ONE4, e7277 (2009).
  • Roberts MT, Mendelson M, Meyer P, Carmichael A, Lever AM. The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. J. Infect.47, 251–255 (2003).
  • Schoeman JF, Andronikou S, Stefan DC, Freeman N, van Toorn R. Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases. J. Child. Neurol.25, 822–828 (2010).
  • Buonsenso D, Serranti D, Valentini P. Management of central nervous system tuberculosis in children: light and shade. Eur. Rev. Med. Pharmacol. Sci.14, 845–853 (2010).
  • Schoeman JF, Springer P, van Rensburg AJ et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J. Child. Neurol.19, 250–257 (2004).
  • Gourie-Devi M, Satish Chandra P. Hyaluronidase as an adjuvant in the treatment of cranial arachnoiditis (Hydrocephalus and optochiasmatic arachnoiditis) complicating tuberculous meningitis. Acta. Neurol. Scand.62, 368–381 (1980).
  • Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection25, 233–239 (1997).
  • Kalkan A, Serhatlioglu S, Ozden M et al. Paradoxically developed optochiasmatic tuberculoma and tuberculous lymphadenitis: a case report with 18-month follow-up by MRI. South Med. J.99, 388–392 (2006).
  • Poon WS, Ahuja A, Li AK. Optochiasmatic tuberculoma causing progressive visual failure: when has medical treatment failed? Postgrad. Med. J.69, 147–149 (1993).
  • Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin. Infect. Dis.47, e83–e85 (2008).
  • Stefan DC, Andronikou S, Freeman N, Schoeman J. Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia. J. Child. Neurol.24, 166–169 (2009).
  • Yeh S, Cunningham MA, Patronas N, Foroozan R. Optic neuropathy and perichiasmal tuberculomas associated with Mycobacterium tuberculosis meningitis in pregnancy. Can. J. Ophthalmol.44, 713–715 (2009).
  • Sunbul M, Leblebicioglu H, Turan D et al. Permanent visual loss despite appropriate therapy in tuberculous meningitis. South Med. J.100, 228–229 (2007).
  • Meyer S, Struffert T, Gottschling S. Tuberculous meningitis. Lancet367, 1682 (2006).
  • Sodhi PK, Grover SB, D Singh, Gulati P. Diagnosis of optochiasmatic tuberculosis revealed by computed tomography and magnetic resonance imaging. Ann. Ophthalmol.33, 252–256 (2001).
  • Silverman IE, Liu GT, Bilaniuk LT, Volpe NJ, Galetta SL. Tuberculous meningitis with blindness and perichiasmal involvement on MRI. Pediatr. Neurol.12, 65–67 (1995).
  • Kingsley DP, Hendrickse WA, Kendall BE, Swash M, Singh V. Tuberculous meningitis: role of CT in management and prognosis. J. Neurol. Neurosurg. Psychiatry50, 30–36 (1987).
  • Ghosh AK, Agrawal A, Singhal S. Tubercular optochiasmatic arachnoiditis. Iranian J. Radiol.6, 101–102 (2009).
  • Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J. Child. Neurol.21, 301–308 (2006).
  • Aliyu SH, Ganesan D, Enoch DA, Watts C, Lever AML. Tuberculous meningitis and hydrocephalus treated successfully with a combination of immunomodulation and cerebrospinal fluid diversion. Infect. Dis. J. Pak.16, 22–24 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.